First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary studyYing Liu, Jufeng Wang, Feng Wang et al.|International Journal of Clinical Oncology|2015Cited by 31
Efficacy and Safety of KH903 Plus FOLFIRI as a Second-Line Treatment in Unresectable Recurrent or Metastatic Colorectal Cancer: A Randomized Phase 2 StudyLi J, Yi Ba, Rongbo Lin et al.|Clinical Colorectal Cancer|2024Cited by 0